1-3 of 3
Manuel L Neves
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) Eligible For High Dose Melphalan (HDM)

Graça Esteves, MD, Manuel L Neves, Helena Martins, Carlos M. Martins, MD, Maria Joao Costa, MD, Sara Valle, MD, Conceição Lopes, MD, João Raposo, MD, Lurdes Guerra, MD, Blanca Polo, MD, Ana Alho, Carolina Viveiros, MD, Susana Mendes, Rita Ferreira, Eduardo Espada, Inês Conde, Daniela Alves, Joao F Lacerda, MD, PhD, Helena Proença, MD, José A Carmo, MD
Journal: Blood
Blood (2013) 122 (21): 1873.
https://doi.org/10.1182/blood.V122.21.1873.1873
Published: 2013
Journal Articles

Lenalidomide Is Effective Treating Patients With Relapsed Multiple Myeloma and Very Severe Renal Impairment

Cristina M. Joao, MD, PhD, Fernando Gomes, MD, Catarina Geraldes, MD, Joana Maria Parreira, MD, Manuel L Neves, Resident, Ines Coelho, MD, Susana Esteves, Msc, Graça V Esteves, MD
Journal: Blood
Blood (2013) 122 (21): 5401.
https://doi.org/10.1182/blood.V122.21.5401.5401
Published: 2013
Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) In The Era Of New Agents Namely On ISS Stage II Patients

Graça V Esteves, MD, Manuel L Neves, Helena F Martins, Maria Joao Costa, MD, Sara Valle, MD, João Raposo, MD, Carlos M. Martins, MD, Lurdes Guerra, MD, Conceição Lopes, MD, Susana Mendes, Ana Alho, Rita Ferreira, Carolina Viveiros, MD, Eduardo Espada, Inês Conde, Daniela Alves, Joao F Lacerda, MD, PhD, Blanca Polo, MD, Helena Proença, MD, José A Carmo, MD
Journal: Blood
Blood (2013) 122 (21): 3150.
https://doi.org/10.1182/blood.V122.21.3150.3150
Published: 2013